Recent Clinical Aspects of Hyperprolactinemia Induced by Antipsychotics

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|6|1|52-64

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.6, Iss.1, 2011-01, pp. : 52-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hyperprolactinemia Induced by Antipsychotics: From Diagnosis to Treatment Approach

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 17, Iss. 1, 2017-06 ,pp. : 38-55

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Management of Antipsychotic‐Induced Hyperprolactinemia

By  

PERSPECTIVES IN PSYCHIATRIC CARE, Vol. 52, Iss. 2, 2016-04 ,pp. : 145-152

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug-induced hypo- and hyperprolactinemia: mechanisms, clinical and therapeutic consequences

By Voicu Victor  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 8, 2013-08 ,pp. : 955-968

Informa Healthcare

Access to resources Recommend Favorite

Emotional Aspects of Hyperprolactinemia

By  

Psychotherapy and Psychosomatics, Vol. 67, Iss. 3, 1998-06 ,pp. : 133-139

Karger

Access to resources Recommend Favorite

Recent Clinical Aspects of Eating Disorders

By  

Reviews on Recent Clinical Trials, Vol. 4, Iss. 1, 2009-01 ,pp. : 63-69

Bentham Science Publishers

Access to resources Recommend Favorite